ISPR

Ispire Technology Inc. Common Stock (ISPR)

Stock · NASDAQ · Health Care

$1.35as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

IKE Tech Launches IKE 2.0 for Regulated Products. IKE Tech has introduced IKE 2.0, a tool designed to help regulated products maintain continuous compliance. This product launch is relevant to Ispire Technology as it addresses specific needs within the regulatory sector. The move may influence how the company is perceived in terms of its product offerings and market positioning.

Active signals

High Beta54.4%
200 SMA Touch0.0%
Resistance level
$1.65
Industry
Medicinal Chemicals and Botanical Products

What ISPR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike25-6.3%40%
Bollinger Band Breakdown18-2.0%50%
Bollinger Band Breakout10-11.3%10%
200-Day Moving Average TouchActive now3-0.7%33%
Any 20-session window (baseline)-6.2%33%

Computed by MarketWall from daily closing prices since January 19, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About ISPR

Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Aspire brands. It sells its products through distributors. The company was founded in 2010 and is headquartered in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited.

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
88

Fundamentals

1-day range
$1.42$1.51
Market cap
$95.28M
P/E (trailing)
—
P/E (forward)
6.00
EPS (trailing)
$-0.58
Dividend yield
—
Beta
2.16
Avg. volume
27.1K
52-week range
$1.01$3.87
Next earnings: November 5, 2026 · EPS estimate $-0.03confirmed

How Ispire Technology Inc. Common Stock Makes Money

Where the revenue actually goes — FY2026 annual results

market-wall.comTotalRevenue$96.01MCost of Revenue$83.72M (87%)SG&A$24.17M (25%)Tax$1.15M (1%)ISPR

Source: 10-K filed Sep 15, 2026 · via SEC EDGAR / Finnhub

Gross Profit$12.30M(13%)
Operating Income-$32.59M(-34%)

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$6.5
+381.5%
Median
$4.9
+263.0%
Low
$3.3
+144.4%

Ispire Technology Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • ISPR
    Ispire Technology Inc. Common Stock
    $1.35
    ▼ 6.25%
    Market cap $95.28MP/E —
    $1.01$3.87
  • FTLF
    FitLife Brands Inc. Common Stock
    $8.39
    ▼ 2.21%
    Market cap $95.88MP/E 12.92
    $8.5$20.15
  • BTMD
    Biote Corp. Class A Common Stock
    $1.09
    ▼ 2.25%
    Market cap $61.26MP/E 6.81
    $1$3.26
  • NAII
    Natural Alternatives International Inc. Common Stock
    $1.15
    ▲ 2.68%
    Market cap $14.94MP/E —
    $1.08$4.96
  • MTEX
    Mannatech Incorporated Common Stock
    $7.13
    ▲ 0.00%
    Market cap $9.84MP/E —
    $3.8$12.45
  • BON
    Bon Natural Life Limited Class A Ordinary Shares
    $1.14
    ▲ 0.53%
    Market cap $8.86MP/E —
    $0.95$2.34
  • MDWD
    MediWound Ltd. Ordinary Shares
    $11.85
    ▼ 2.95%
    Market cap $183.44MP/E —
    $11.9$20.03

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
145.1K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
4.61M
Total value held
$5.73M
Institutional holders
58
Top holders this quarter
  • Unknown1.50M
  • Unknown1.26M
  • Unknown496.5K
  • Unknown344.3K
  • Unknown198.5K
  • Unknown151.3K
  • Unknown87.4K
  • Unknown76.7K
  • Unknown67.3K
  • Unknown55.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.